HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christer Sundström Selected Research

Immunoglobulin Variable Region

7/2005Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
6/2005Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.
8/2003More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia.
4/2003Ex vivo drug and irradiation sensitivities in hypermutated and unmutated forms of chronic lymphocytic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christer Sundström Research Topics

Disease

22Lymphoma (Lymphomas)
03/2022 - 01/2002
18Neoplasms (Cancer)
03/2022 - 04/2003
14B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2010 - 03/2002
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2021 - 02/2006
8B-Cell Lymphoma (Lymphoma, B Cell)
01/2015 - 01/2006
7Hodgkin Disease (Hodgkin's Disease)
06/2020 - 01/2002
7Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2017 - 04/2002
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2011 - 07/2005
5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2021 - 05/2015
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 12/2009
4Infections
01/2014 - 12/2004
3Rheumatoid Arthritis
01/2021 - 01/2006
3Residual Neoplasm
03/2017 - 01/2009
3Leukemia
12/2011 - 04/2007
2Disease Progression
01/2021 - 06/2002
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2007 - 06/2002
2Inflammation (Inflammations)
12/2006 - 11/2005
1Rheumatic Diseases (Rheumatism)
03/2022
1Epstein-Barr Virus Infections
10/2016
1Hepatitis C
05/2014
1Glioblastoma (Glioblastoma Multiforme)
01/2014
1Glioma (Gliomas)
01/2014
1Medulloblastoma
01/2014
1Meningioma (Meningiomas)
01/2014
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2012
1Pathologic Complete Response
09/2012
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2012
1T-Cell Leukemia (Leukemia, T Cell)
02/2010
1Carcinogenesis
12/2008
1Thrombocytopenia (Thrombopenia)
01/2008
1Neutropenia
01/2008
1Hypersensitivity (Allergy)
01/2007
1Sclerosis
04/2006

Drug/Important Bio-Agent (IBA)

9Rituximab (Mabthera)FDA Link
03/2017 - 01/2006
8Immunoglobulins (Immunoglobulin)IBA
03/2011 - 03/2002
6Proteins (Proteins, Gene)FDA Link
01/2014 - 06/2002
5Pharmaceutical PreparationsIBA
01/2021 - 01/2002
5AntigensIBA
01/2020 - 04/2002
4Immunoglobulin Variable RegionIBA
07/2005 - 04/2003
3LigandsIBA
03/2022 - 01/2019
3Biological ProductsIBA
01/2021 - 08/2003
2Forkhead Transcription Factors (Forkhead Box Proteins)IBA
06/2020 - 05/2015
2Biomarkers (Surrogate Marker)IBA
06/2020 - 12/2009
2Cytarabine (Cytosar-U)FDA LinkGeneric
11/2016 - 07/2014
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
08/2013 - 12/2004
2Surface Antigens (Surface Antigen)IBA
07/2005 - 01/2003
2MitogensIBA
07/2005 - 08/2003
2EpitopesIBA
11/2004 - 06/2003
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
06/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2019
1Biocompatible Materials (Biomaterials)IBA
02/2018
1Proteasome InhibitorsIBA
01/2017
1Lenalidomide (CC 5013)FDA Link
10/2016
1Bendamustine HydrochlorideFDA Link
10/2016
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2016
1HLA-A1 Antigen (HLA A1 Antigen)IBA
10/2016
1MicroRNAs (MicroRNA)IBA
04/2015
1InterferonsIBA
01/2015
1Antiviral Agents (Antivirals)IBA
01/2014
1AntibodiesIBA
01/2014
1DNA (Deoxyribonucleic Acid)IBA
08/2013
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
08/2013
1Anaplastic Lymphoma KinaseIBA
09/2012
1Immunoglobulin A (IgA)IBA
02/2012
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2011
1Therapeutic UsesIBA
06/2011
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2011
1Transcription Factors (Transcription Factor)IBA
06/2010
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2010
1Angiogenesis InhibitorsIBA
09/2009
1Antigen Receptors (Antigen Receptor)IBA
08/2009
1Prednisolone (Predate)FDA LinkGeneric
07/2009
1RolipramIBA
07/2009
1Antineoplastic Agents (Antineoplastics)IBA
07/2009
1leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
12/2008
1CalciumIBA
12/2008
1cysteinyl-leukotrieneIBA
12/2008
1Arachidonic Acid (Vitamin F)IBA
12/2008
1EnzymesIBA
04/2008
1ImmunosorbentsIBA
04/2008
1Interferon-alpha (Interferon Alfa)IBA
01/2008
1ThioredoxinsIBA
11/2007
1Immunoglobulin E (IgE)IBA
01/2007
1AllergensIBA
01/2007
1Fatty Acids (Saturated Fatty Acids)IBA
12/2006
1Dietary FiberFDA Link
12/2006
1Vitamin DFDA LinkGeneric
12/2006
1Interleukin-9 (Interleukin 9)IBA
04/2006
1ORALIT (ORS)IBA
03/2006
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2006
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2006
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2006
1Anti-Bacterial Agents (Antibiotics)IBA
11/2005
1Imatinib Mesylate (Gleevec)FDA Link
07/2005

Therapy/Procedure

15Therapeutics
06/2021 - 06/2002
8Drug Therapy (Chemotherapy)
01/2020 - 01/2002
6Stem Cell Transplantation
03/2017 - 02/2010
3Organ Transplantation
06/2021 - 05/2014
2Transplantation
06/2020 - 09/2012
1Immunomodulation
01/2020